oxyphenbutazone has been researched along with Precancerous Conditions in 2 studies
Oxyphenbutazone: A non-steroidal anti-inflammatory drug. Oxyphenbutazone eyedrops have been used abroad in the management of postoperative ocular inflammation, superficial eye injuries, and episcleritis. (From AMA, Drug Evaluations Annual, 1994, p2000) It had been used by mouth in rheumatic disorders such as ankylosing spondylitis, osteoarthritis, and rheumatoid arthritis but such use is no longer considered justified owing to the risk of severe hematological adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p27)
oxyphenbutazone : A metabolite of phenylbutazone obtained by hydroxylation at position 4 of one of the phenyl rings. Commonly used (as its hydrate) to treat pain, swelling and stiffness associated with arthritis and gout, it was withdrawn from the market 1984 following association with blood dyscrasis and Stevens-Johnson syndrome.
Precancerous Conditions: Pathological conditions that tend eventually to become malignant.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Scribner, JD | 1 |
Slaga, TJ | 1 |
Stiglbauer, R | 1 |
2 other studies available for oxyphenbutazone and Precancerous Conditions
Article | Year |
---|---|
Influence of nonsteroid anti-inflammatory agents on protein synthesis and hyperplasia caused by a tumor promoter.
Topics: Acetates; Alcohols; Animals; Anti-Inflammatory Agents; Carcinogens; Cytosol; Diterpenes; Fatty Acids | 1974 |
[On a new possibility in the management of exudative radiodermatitis].
Topics: Aged; Anti-Inflammatory Agents; Carcinoma; Carcinoma, Basal Cell; Ear, External; Exudates and Transu | 1967 |